Direkt zum Inhalt
Merck

SHPH2

MISSION® LentiPlex® Human Pooled shRNA Library TRC2

For Rapid, Convenient Genome-wide shRNA Screens

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

1 SET

CHF 4’930.00

CHF 4’930.00


Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragenWeitere Informationen anfragen

Über diesen Artikel

NACRES:
NA.51
UNSPSC Code:
41105904
Concentration:
≥5x108 VP/ml (via p24 assay)
Technique(s):
capture ELISA: 5 x 108 TU/mL using p24

Fortfahren mit

Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten

product line

MISSION®

concentration

≥5x108 VP/ml (via p24 assay)

technique(s)

capture ELISA: 5 x 108 TU/mL using p24

shipped in

dry ice

storage temp.

−70°C

Quality Level

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel
SHPH15SHPM2SHPM15
technique(s)

capture ELISA: 5 x 108 TU/mL using p24

technique(s)

capture ELISA: 5 x 108 TU/mL using p24

technique(s)

capture ELISA: 5 x 108 TU/mL using p24

technique(s)

capture ELISA: 5 x 108 TU/mL using p24

product line

MISSION®

product line

MISSION®

product line

MISSION®

product line

MISSION®

concentration

≥5x108 VP/ml (via p24 assay)

concentration

≥5x108 VP/ml (via p24 assay)

concentration

≥5x108 VP/ml (via p24 assay)

concentration

≥5x108 VP/ml (via p24 assay)

storage temp.

−70°C

storage temp.

−70°C

storage temp.

−70°C

storage temp.

−70°C

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

General description

MISSION LentiPlex Pooled Libraries bring the power of the MISSION TRC shRNA collection together with Sigma′s lentiviral manufacturing expertise to enable genome-wide RNAi screens at your bench-top. The LentiPlex pooled system provides enhanced delivery and long-term gene silencing in non-dividing and primary cell lines allowing unlimited discovery potential. The convenient format now makes rapid whole-genome RNAi screens accessible to any researcher with minimal reagent, time or capital equipment investment.

The MISSION LentiPlex Human shRNA Pooled Library 2.0 includes additional gene and clone coverage from the previously offered LentiPlex 1.0 Pooled Library . With the addition of 2.0, which consists of 5,000+ human genes and 20,000+ total clone coverage divided into 3 subpools, the complete whole-genome human library complete whole-genome human librarynow consists of over 125,000 shRNA constructs from the TRC collection targeting 20,000+ human genes. Each library is tested for shRNA representation before product release to ensure robust library coverage. The complete library is provided in ready-to-use lentiviral format at titers of at least 5 x 108 TU/ml via p24 assay and is pre-divided into sixteen subpools of approximately 6,000-8,000 shRNA constructs each. Amplification and sequencing primers are also provided for downstream target identification.

For more information including sample data and uses, please visit our LentiPlex Technical Detail Page.

Other Notes

Browse additional MISSION shRNA Gene Family Sets in our MISSION shRNA portal
The MISSION LentiPlex Human Pooled shRNA Libraries consist of Catalog Numbers SHPH01, SHPH15, SHPH2, and SHPHLIBR. Please refer to Table 1 for approximate number of shRNA clone coverage, targeted genes, and subpools for each library.

Amplification and sequencing primers are also provided for downstream hit identification.

Deconvolution of shRNA Pools
Sigma′s deconvolution service lets you easily identify the genes that impact your pooled shRNA screen.

  • Next-generation sequencing of clonesgives a precise number of individual clone occurrence within a pooled shRNA sample
  • Comprehensive, reproducible results from pooled shRNA screens
  • Statistically robust and information-rich data

Contact your local Sigma sales representative for more information or submit an inquiry to MISSION RNAi

Legal Information

LentiPlex is a registered trademark of Merck KGaA, Darmstadt, Germany
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Lagerklasse

12 - Non Combustible Liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Christine Karlsson et al.
Methods in molecular biology (Clifton, N.J.), 650, 29-43 (2010-08-06)
Identifying the genes and pathways that regulate self-renewal and differentiation in somatic stem cells is a central goal in stem cell and cancer biology. Here, we describe a method for RNAi-based screens in primary human hematopoietic stem and progenitor cells.
Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK.
Lin, Yu-yi, et al.
Nature (2012)
Richard Possemato et al.
Nature, 476(7360), 346-350 (2011-07-16)
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology

Artikel

RNAi Consortium (TRC): Collaborative effort among academic labs and biotech/pharma institutes advancing RNA interference research.

Verwandter Inhalt

Un criblage de cibles thérapeutiques et de leads fructueux nécessite des réactifs et du matériel testés, adaptés à la procédure et au haut débit. Trouvez les bons outils pour vos procédés CRO, pharma ou biotech pour le criblage de petites molécules et de produits biologiques, et pour des tests d'immunogénicité robustes afin de garantir la sécurité thérapeutique.

High-throughput reagents for drug target screening and immunogenicity testing.

Uno screening di successo per l’identificazione di target farmacologici e di composti guida (lead) richiede reagenti e materiali testati, compatibili con il processo e ad alta efficienza. Trovate le soluzioni adatte al vostro processo, che operiate in un'azienda farmaceutica, biotecnologica o in una CRO, per lo screening di piccole molecole o di biofarmaci e per saggi di immunogenicità robusti finalizzati a garantire la sicurezza terapeutica.

Für ein erfolgreiches Screening nach Wirkstoffzielen und die Entdeckung von Leitstrukturen sind getestete, prozesssichere Reagenzien und Verbrauchsmaterialien für einen hohen Durchsatz erforderlich. Finden Sie die richtigen Werkzeuge für Ihre CRO-, Pharma- oder Biotech-Prozesse für das Screening von kleinen Molekülen und Biologika sowie für robuste Immunogenitätstests zur Therapiesicherheit.

Alle anzeigen

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung